Lilac Software

Name: Lilac Software
Brand: Lilac Software

AI Native

A modern, cloud native Payer Analytics Stack to drive better business & health outcomes

Est 2023|Raised $30K

LinkedIn 2K|Website|FTEs 6|HQ New York, New York, US

MarketsBusiness Intelligence (BI) and Analytics

01Competitive Landscape

Narrative analysis

- Lilac vs Medisolv: Post-acquisition, Lilac’s functionality may be integrated into Medisolv’s portfolio. Existing Medisolv customers may benefit from integration; independent buyers should assess integration plans and continuity. - Lilac vs HealthEdge: HealthEdge is a core administration platform and addresses different procurement needs. Lilac is positioned as an analytics and quality performance layer rather than a claims adjudication system. - Lilac vs Inovalon/MedeAnalytics: Established analytics vendors have broader market presence and more visible customer references. Lilac’s vendor materials emphasize cloud-based architecture and AI-assisted workflows; independent validation of those differentiators is limited in retrieved sources.

Market share / adoption trends

No authoritative third-party market share data for Lilac was found in the retrieved sources. Given its apparent early-stage profile and recent acquisition, adoption is likely smaller than incumbent platforms.

	Lilac Software (Product overview and feature pages)	Medisolv (ENCOR platform)	HealthEdge (HealthRules Payor ecosystem)
Starting Price	Not publicly listed (enterprise/custom)	Public example pricing for certain registry measures; other modules vary	Not publicly listed (enterprise/custom)
Primary Use Case	MA Stars and payer analytics with data harmonization and quality measurement focus	Quality measurement and reporting for providers/health systems; registry capabilities	Core payer administration and claims processing with analytics modules
Key Strength	Focused MA Stars and payer analytics positioning; vendor claims SOC 2 Type II; newly acquired by Medisolv	Established presence in provider quality measurement and reporting	Enterprise-scale core administration; broad market recognition claimed by vendor
Key Weakness	Limited independent reviews and limited public technical/security documentation; pricing opacity	Pricing that can scale with clinician counts/measures; provider-centric origin	Potentially complex implementations and broader suite may be heavier than a focused analytics tool

01Competitive Landscape

Narrative analysis

Lilac vs Medisolv: Post-acquisition, Lilac’s functionality may be integrated into Medisolv’s portfolio. Existing Medisolv customers may benefit from integration; independent buyers should assess integration plans and continuity.
Lilac vs HealthEdge: HealthEdge is a core administration platform and addresses different procurement needs. Lilac is positioned as an analytics and quality performance layer rather than a claims adjudication system.
Lilac vs Inovalon/MedeAnalytics: Established analytics vendors have broader market presence and more visible customer references. Lilac’s vendor materials emphasize cloud-based architecture and AI-assisted workflows; independent validation of those differentiators is limited in retrieved sources.

Market share / adoption trends

	Lilac Software (Product overview and feature pages)	Medisolv (ENCOR platform)	HealthEdge (HealthRules Payor ecosystem)
Starting Price	Not publicly listed (enterprise/custom)	Public example pricing for certain registry measures; other modules vary	Not publicly listed (enterprise/custom)
Primary Use Case	MA Stars and payer analytics with data harmonization and quality measurement focus	Quality measurement and reporting for providers/health systems; registry capabilities	Core payer administration and claims processing with analytics modules
Key Strength	Focused MA Stars and payer analytics positioning; vendor claims SOC 2 Type II; newly acquired by Medisolv	Established presence in provider quality measurement and reporting	Enterprise-scale core administration; broad market recognition claimed by vendor
Key Weakness	Limited independent reviews and limited public technical/security documentation; pricing opacity	Pricing that can scale with clinician counts/measures; provider-centric origin	Potentially complex implementations and broader suite may be heavier than a focused analytics tool